Comparison of echocardiographic findings in patients with aldosterone-producing adenomas: adrenalectomy versus mineralocorticoid receptor antagonists

Tatsuya Haze^{1

2

3}

Affiliations

¹ Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan. haze.tat.bg@yokohama-cu.ac.jp.
² Department of Nephrology and Hypertension, Yokohama City University Medical Center, Yokohama, Japan. haze.tat.bg@yokohama-cu.ac.jp.
³ YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Yokohama, Japan. haze.tat.bg@yokohama-cu.ac.jp.

Editorial

Tatsuya Haze. Hypertens Res. 2025 Feb.

. 2025 Feb;48(2):816-818.

doi: 10.1038/s41440-024-02008-8. Epub 2024 Nov 28.

Tatsuya Haze^{1

2

3}

¹ Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan. haze.tat.bg@yokohama-cu.ac.jp.
² Department of Nephrology and Hypertension, Yokohama City University Medical Center, Yokohama, Japan. haze.tat.bg@yokohama-cu.ac.jp.
³ YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Yokohama, Japan. haze.tat.bg@yokohama-cu.ac.jp.

No abstract available

Keywords: Adrenalectomy; Cardiac remodeling; Hypertension; Mineralocorticoid receptor antagonists; Primary aldosteronism.

Conflict of interest statement

Compliance with ethical standards. Conflict of interest: The author declares no competing interests.

Evaluating the effects of adrenalectomy and mineralocorticoid receptor antagonist on cardiac remodeling and diastolic function in patients with aldosterone-producing adenoma.
Chang YC, Wu XM, Chen TY, Chen UL, Liao CW, Lai TS, Chang CC, Lee BC, Yang FY, Chen ZW, Chang YY, Chueh JS, Wu VC, Tsai CH, Hung CS, Lin YH; TAIPAI study group. Chang YC, et al. Hypertens Res. 2025 Feb;48(2):529-539. doi: 10.1038/s41440-024-01946-7. Epub 2024 Oct 25. Hypertens Res. 2025. PMID: 39448809

1. Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, et al. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J. 2022;69:327–59. - DOI - PubMed
1. Marzano L, Colussi G, Sechi LA, Catena C. Adrenalectomy Is Comparable With Medical Treatment for Reduction of Left Ventricular Mass in Primary Aldosteronism: Meta-Analysis of Long-Term Studies. Am J Hypertens. 2014;28:312–18. - DOI - PubMed
1. Aune A, Gerdts E, Kokorina M, Kringeland E, Midtbø H, Løvås K, et al. Persistent cardiac organ damage in surgically and medically treated primary aldosteronism. J Hypertens. 2022;40:1204–11. - DOI - PubMed
1. Puar TH, Cheong CK, Foo RSY, Saffari SE, Tu TM, Chee MR, et al. Treatment of Primary Aldosteronism and Reversal of Renin Suppression Improves Left Ventricular Systolic Function. Front Endocrinol. 2022;13:916744.
1. Pan C-T, Wu X-M, Tsai C-H, Chang Y-Y, Chen Z-W, Chang C-C, et al. Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling in Primary Aldosteronism. Front Endocrinol. 2021;12:646097.